The FDA’s expert panel on vaccines voted Thursday to recommend that anyone who gets a primary Covid vaccine going forward ...

It's part of a plan to offer a single booster to the public each year that gives protection against the most recent, dominant ...

Future COVID-19 vaccines and boosters should be bivalent – meaning they’ll target older strains of the virus as well as the newer omicron BA.4 and BA.5 variants – following a unanimous recommendation ...

The U.S. Food and Drug Administration's vaccine advisory panel on Thursday voted unanimously to recommend that the agency ...

The U.S. Food and Drug Administration’s key science advisory panel, the Vaccines and Related Biological Products Advisory ...

Dr. Kristin Moffitt, an infectious disease specialist at Boston Children's Hospital talks about concerns about COVID vaccines ...

In a document posted ahead of an advisory group meeting on Jan 26, the US Food and Drug Administration (FDA) today spelled ...

At a meeting of this FDA ... Covid-19 and who did not. It found that 1.9% of the study participants who received the original booster became infected. Among those who got the updated bivalent ...

On Jan 26, the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) unanimously recommended moving toward a uniform vaccine strain composition for all COVID-19 vaccine doses ...

The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet Thursday to discuss how to simplify ...

Novavax said Friday it expects its Covid-19 vaccine to remain “an important part” of the country’s immunization plan, as regulators work to develop a long-term strategy to protect the public from the ...

At a meeting of this FDA ... Covid-19 and who did not. It found that 1.9% of the study participants who received the original booster became infected. Among those who got the updated bivalent ...